STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
CERS CERUS CORPORATION StockScouter® Report
3
StockScouter® Score
CERUS CORPORATION, a small cap growth company in the healthcare sector, is expected to slightly underperform the market over the next six months with slightly higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The most recent quarterly earnings report was significantly higher than analysts’ consensus forecast. Positive
Concerns
- Two or more executives, board directors or major shareholders – including one high-level executive -- sold a large number of shares recently. Very negative
- One or more analysts has modestly decreased quarterly earnings estimates for CERS. Negative
- Short-term relative price momentum exhibits meaningful weakness. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that small cap stocks will be out of favor, growth stocks will be out of favor, and healthcare stocks will be out of favor.
Expected Risk/Return
Core Model Grades
C
F
C
C